Menu Search
Equities

JOHNSON DRN

JNJB34:SAO

JOHNSON DRN

Actions
  • Price (BRL)60.51
  • Today's Change1.91 / 3.26%
  • Shares traded7.40k
  • 1 Year change+22.81%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 09:45 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		JNJ:NYQ since
announced		Transaction
value
V-Wave LtdDeal completed20 Aug 202420 Aug 2024Deal completed-2.59%1.70bn
Shockwave Medical IncDeal completed05 Apr 202405 Apr 2024Deal completed1.97%14.07bn
Ambrx Biopharma IncDeal completed08 Jan 202408 Jan 2024Deal completed-3.49%1.98bn
Data delayed at least 15 minutes, as of Nov 22 2024.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Ita� Unibanco SAas of 30 Jun 2024192.82k0.00%
Banco J. Safra SAas of 30 Jun 2024125.10k0.00%
Safra Asset Management Ltda.as of 30 Jun 202486.10k0.00%
BRAM - Bradesco Asset Management SA DTVMas of 30 Jun 202477.51k0.00%
Caixa DTVM SAas of 30 Jun 202436.39k0.00%
Warren Brasil Gest�o e Administra��o e Recursos Ltda.as of 30 Jun 20249.69k0.00%
Morgan Stanley Administradora de Carteiras SAas of 30 Jun 202451.000.00%
BTG Pactual WM Gest�o de Recursos Ltda.as of 31 Oct 20230.000.00%
More ▼
Data from 30 Jun 2024 - 13 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.